Navigation Links
Live cell imaging reveals distinct alterations of subcellular glutathione potentials
Date:4/17/2014

In the April issue of Experimental Biology and Medicine a multidisciplinary research team led by Drs. Rex Gaskins and Paul Kenis in the Institute of Genomic Biology (IGB) on the campus of the University of Illinois Urbana-Champaign describe their recent work on subcellular redox homeostasis. Intracellular reduction-oxidation reactions underlie a variety of cell functions including energy metabolism, signaling, and transcriptional processes. Due to these crucial roles in regulating normal cellular behavior, redox status has been recognized as a key area of biological research in various diseases, including cancer.

Oxidative states are generally considered to be indicative of cellular stress; however, cells inherently release harmful reactive oxygen species during energy production, neutralized by intracellular antioxidative buffering systems. The recent development of genetically-encoded fluorescent biosensors specific to glutathione (GSH), the most abundant cellular redox buffer, has facilitated the IGB research group's discovery of distinct alterations of glutathione redox potentials in the cytosol versus mitochondria within the cell.

"The highly sensitive probe Grx1-roGFP2 enabled us to monitor rapid compartmentalized changes in the glutathione redox potentials in live cells. The complex redox interactions between organelles are significant to maintaining cellular health and imbalances may contribute to the transformation of tumor cells," said Dr. Vladimir Kolossov, corresponding author.

The changes in fluorescence intensity of the probe correspond to the alterations of oxidized:reduced GSH, which is highly indicative of overall redox balance. Time lapse images collected on a Zeiss Axiovert 200M fluorescence microscope in the core imaging facility of IGB allowed real-time monitoring of the redox state in the cytosol and mitochondria of live cells.

"In modern biology mitochondria are considered to be much more than the powerhouse of the cell; they integrate multiple intracellular signals to regulate progression through the cell cycle and into apoptosis. Therefore it is vital that they maintain optimal functionality to prevent the development of abnormal cells," states co-author Jessica Beaudoin.

With this in vivo model, the research team uncovered evidence of distinct organellar perturbations in redox balance following inhibition of GSH synthesis with buthionine sulfoximine, demonstrating increased mitochondrial oxidation in response to GSH depletion compared to the cytosol. The effect was observed in multiple mammalian cell lines, including both normal and tumorigenic models. Taken together, these findings indicate different redox requirements for the glutathione thiol/disulfide redox couple within cytosol and mitochondria of resting cells and reveal distinct regulation of their redox poise in response to inhibition of glutathione biosynthesis.

Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine, said "Kolossov et al have utilized a genetically-encoded redox probe that has the ability to determine oxidized/reduced glutathione levels within different cellular compartments of living cells. This will be an important approach for studying redox changes in disease states including cancer, neurodegenerative disorders, cardiovascular disease, sickle cell disease and many others which are known to involve oxidative stress".


'/>"/>

Contact: Vladimir L. Kolossov
viadimer@illinois.edu
Society for Experimental Biology and Medicine
Source:Eurekalert

Related medicine news :

1. Live imaging shows response to cancer drugs can be boosted by altering tumor microenvironment
2. MR enterography is as good or better than standard imaging exams for pediatric Crohns patients
3. Use of dedicated pediatric imaging departments for pediatric CT reduces radiation dose
4. Low-dose whole-body CT finds disease missed on standard imaging for patients with multiple myeloma
5. Study examines necessity of additional imaging in PET/CT oncologic reports
6. Fox Chase researchers find no disparities in imaging before breast cancer surgery
7. Piramal imaging to present data at Society for Nuclear Medicine Annual Meeting
8. Mount Sinai is first in New York state to perform new Alzheimers imaging test in clinical setting
9. Imaging agents predict breast cancer response to endocrine therapy
10. Noninvasive imaging technique may help kids with heart transplants
11. Fighting obesity with thermal imaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/26/2017)... ... September 26, 2017 , ... ... Device Manufacturers, **An FDAnews Management Report**, http://www.fdanews.com/products/54648-principles-of-equipment-qualification      , ... Manufacturers must prove that their equipment, operations and processes all work the ...
(Date:9/26/2017)... ... September 26, 2017 , ... Dr. Kovatis, is a Hospital ... Ankle, and Foot Section of the Department of Orthopedic Surgery at Hackensack University ... Hackensack UMC performing total ankle replacements. Because of this, Dr. Kovatis is often ...
(Date:9/26/2017)... ... 26, 2017 , ... DETECTO has been awarded ... 2017, the new agreement allows Premier members, at their discretion, to take advantage ... is pleased to renew our agreement with Premier to be able to supply ...
(Date:9/26/2017)... ... September 26, 2017 , ... “Good Morning Sunshine!: Finding Strength ... overcoming obstacles. “Good Morning Sunshine!: Finding Strength and Comfort in God” is the creation ... from Fort Hays Sate University, who has worked at a local mental health center ...
(Date:9/26/2017)... ... September 26, 2017 , ... “Childhood Memories of a ... draw readers back, and help them relive their own youth. “Childhood Memories of a ... operator in the US Navy for nine years. He received his BS from ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... TORONTO , Sept. 6, 2017 /PRNewswire/ ... new knowledge and skills while treating their ... for hands-on experience without involving patients. Simulation ... skills. Clinicians can carry out procedures, refine ... at risk. Integration of new technology, such ...
(Date:9/6/2017)... -- NeuroRx, a clinical stage biopharma company developing the first ... been granted Fast Track status by the US Food and ... followed by NRX-101 (D-cycloserine + lurasidone). The company will shortly ... therapy targeting patients who are admitted to Emergency Departments with ... ...
(Date:9/5/2017)... -- Sapheneia and Scannerside received FDA 510(k) clearance to ... third-party Vendor neutral CT product that makes it affordable ... current MITA standards. ... specifically designed to provide CT operators, prior to a ... a predefined threshold. Scannerside Dose Check is intended to ...
Breaking Medicine Technology: